Sleep
Top news from NAMS: Treatments for vaginal odor, vasomotor symptoms, sleep issues and more
The Healio editors have compiled the most read news from the NAMS annual meeting in October.
Sleep study measurements predict underlying cardiopulmonary disease
NASHVILLE, Tenn. — Among patients undergoing a sleep study, two oxygenation benchmarks demonstrated utility as screening tools for predicting underlying cardiopulmonary disease, according to study results.
Pain, sleep, mood disorders most common comorbidities in patients with narcolepsy
CHICAGO — Pain, sleep and mood disorders were the most commonly found comorbidities among those with narcolepsy, with chronic pain being more than twice as likely to occur compared with matched controls, a poster showed at ANA 2022.
Addition of sleep metric in updated Life’s Essential 8 predicts CVD incidence
The incorporation of sleep as a CV health metric, as recently done with the American Heart Association’s updated Life’s Essential 8 risk calculator, may enhance CVD primordial and primary prevention efforts, data show.
Fezolinetant improves vasomotor symptom severity, associated sleep disturbances
Women taking fezolinetant for moderate to severe vasomotor symptoms experienced a reduction in symptom severity and sleep disturbances, according to data presented at the NAMS Annual Meeting.
Migraines linked to poor sleep for premenopausal and perimenopausal women
Premenopausal and perimenopausal women with a history of migraines were more likely to experience poor sleep vs. those who did not have a history of migraines, according to a cross-sectional study presented at the NAMS Annual Meeting.
More than half of hospitalized patients with heart failure have sleep apnea
More than half of hospitalized adults with HF have obstructive sleep apnea or central sleep apnea, with male sex, higher BMI, higher heart rate and more comorbidities predicting sleep-disordered breathing, researchers reported.
Sleep society issues health advisory amid rise in melatonin use among kids
The American Academy of Sleep Medicine has released an advisory encouraging parents to talk to health care professionals before giving their children melatonin or other sleep aid supplements.
Dupilumab shows efficacy, safety in infants, young children with atopic dermatitis
Dupilumab significantly improved the signs and symptoms of moderate to severe atopic dermatitis as well as quality of life among patients aged 6 months to younger than 6 years, according to a study published in The Lancet.
Allergists vary in how they perform sleep assessments
Although patients with asthma and other atopic conditions experience higher risks for sleep disorders, allergists vary in how they address their patients’ sleep, according to findings presented in a research letter.